FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T-and B-cell responses to FVIII

Yoon, J; Schmidt, A; Zhang, AH; Konigs, C; Kim, YC; Scott, DW

Kim, YC; Scott, DW (reprint author), Uniformed Serv Univ Hlth Sci, Dept Med, 4301 Johns Bridge Rd, Bethesda, MD 20814 USA.

BLOOD, 2017; 129 (2): 238

Abstract

Replacement therapy with factor VIII (FVIII) is used in patients with hemophilia A for treatment of bleeding episodes or for prophylaxis. A common and......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索